Furthermore, a study by Philipp et al. uncovered that the presence of ctDNA was correlated with carcinoembryonic antigen expression and that ctDNA status was a stronger prognostic biomarker than tumor stage in CRC. This evidence concerns the gene CEACAM5 and colorectal carcinoma.